BMRN
Biomarin Pharmaceutical Inc
Price:  
56.70 
USD
Volume:  
1,940,786.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biomarin Fair Value

-83.38 %
Upside

What is the fair value of Biomarin?

As of 2026-11-13, the Fair Value of Biomarin Pharmaceutical Inc (BMRN) is 9.42 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 56.70 USD, the upside of Biomarin Pharmaceutical Inc is -83.38%.

Is Biomarin a good investment?

With the market price of 56.70 USD and our fair value calculation, Biomarin Pharmaceutical Inc (BMRN) is not a good investment. Investing in Biomarin stocks now will result in a potential loss of 83.38%.

56.70 USD
Stock Price
9.42 USD
Fair Price
FAIR VALUE CALCULATION

Biomarin Fair Value

Peter Lynch's formula is:

Biomarin Fair Value
= Earnings Growth Rate x TTM EPS
Biomarin Fair Value
= 25.00 x 0.38
Biomarin Fair Value
= 9.42

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31 5Y Avg
Net income -64.10 141.60 167.65 426.86 348.90 204.18
YoY growth -107.46% 320.90% 18.39% 154.62% -18.26% 73.64%

Biomarin Fair Value - Key Data

Market Cap (mil) 10,975.42
P/E 150.41x
Forward P/E 21.60x
EPS 0.38
Avg earnings growth rate 73.64%
TTM earnings 72.97